OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
批准号:
6039159
负责人:
ROBERT MICHAEL KESSLER
金额:
$47.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31
中文摘要
描述:(逐字摘自申请者的摘要)抗精神病药物的作用
典型的抗精神病药是通过阻断多巴胺D2型受体介导的。
有人提出,这些药物的抗精神病作用是由
在锥体外区阻断皮质和边缘多巴胺D2受体
部位效应是由纹状体背外侧D2受体阻断所介导的。至
DATE、MOST和SPECT对抗精神病药物阻断D2受体的研究
已经检查了纹状体。有许多研究表明,
氯氮平的非典型分布至少部分是通过选择性地
对皮质和边缘多巴胺能神经传递的影响。我们的团队已经
[18F]N-烯丙基-5-氟丙基吡啶作为PET放射性配体的研制
人类纹状体外D2受体的可视化研究。我们的第一阶段和早期阶段
II IND研究表明,该配体允许良好的可视化和
人纹状体外D2受体的定量测定。我们建议使用[18F]
N-烯丙基-5-氟丙哌啶PET研究评价15例精神分裂症
受试者停止服药,并在氟哌啶醇单一治疗6周后,AS
以及15名精神分裂症患者停药后8周
氯氮平单一疗法。这些研究的数据将允许对以下方面进行评估
无论是氯氮平、S还是氟哌啶醇(一种典型的抗精神病药物),
选择性地占据纹状体外的多巴胺D2受体,以及是否局部
D2受体的占用可能与抗精神病作用有关。次要的
目标包括检查精神病理症状复合体,即,
积极的、消极的、混乱的以及认知异常
精神分裂症与D2受体的区域水平有关。
英文摘要
DESCRIPTION: (Verbatim from the Applicant's Abstract) The antipsychotic effects
of typical neuroleptics are mediated by blockade of dopamine D2 type receptors.
It has been proposed that the antipsychotic effects of these drugs are mediated
by blockade of cortical and limbic dopamine D2 receptors while extrapyramidal
site effects are mediated by dorsolateral striatal D2 receptor blockade. To
date, most PET and SPECT studies of antipsychotic drug blockade of D2 receptors
have examined the striatum. There are a number of studies which suggest that
the atypical profile of clozapine is mediated at least in part by selective
effects on cortical and limbic dopaminergic neurotransmission. Our group has
developed [18F] N-allyl-5-fluoropropylepidepride as a PET radioligand for
visualization of extrastriatal D2 receptors in man. Our Phase I and early Phase
II IND studies demonstrate that this ligand allows excellent visualization and
quantitation of extrastriatal D2 receptors in man. Wed propose to use [18F]
N-allyl-5-fluoropropylepidepride PET studies to evaluate 15 schizophrenic
subjects off medication and following 6 weeks of haloperidol monotherapy, as
well as 15 schizophrenic subjects off medication and following 8 weeks of
clozapine monotherapy. The data from these studies will allow evaluation as to
whether clozapine, s compared to haloperidol (a typical neuroleptic),
selectively occupies extrastriatal dopamine D2 receptors, and whether regional
occupancy of D2 receptors can be related to antipsychotic effects. Secondary
goals include examining if psychopathological symptom complexes, i.e.,
positive, negative, and disorganization, as well as cognitive abnormalities in
schizophrenia are related to regional levels of D2 receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
-
批准号:8841983
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2014
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
-
批准号:9304643
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2014
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
-
批准号:9763544
-
项目类别:
-
资助金额:$48.96万
-
财政年份:2014
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
PET IMAGING OF EXTRASTRIATAL DOPAMINE LEVELS
-
批准号:7731405
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2006
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
PET IMAGING OF EXTRASTRIATAL DOPAMINE LEVELS
-
批准号:7605580
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2006
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
PET IMAGING OF EXTRASTRIATAL DOPAMINE LEVELS
-
批准号:7375659
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2005
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Pet Imaging of Extrastriatial Dopamine Levels
-
批准号:6945829
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Small Animal PET Scanner
-
批准号:6581711
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Pet Imaging of Extrastriatial Dopamine Levels
-
批准号:6678142
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Pet Imaging of Extrastriatial Dopamine Levels
-
批准号:6800018
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
-
批准号:6343768
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2000
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
-
批准号:6490869
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2000
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:2247333
-
项目类别:
-
资助金额:$20.37万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:3386765
-
项目类别:
-
资助金额:$19.18万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:3386764
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:3386766
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
海外基金